Advances in Brief Amplification and Overexpression of Androgen Receptor Gene in Hormone-Refractory Prostate Cancer 1
暂无分享,去创建一个
R L Vessella | T. Tammela | R. Vessella | T. Visakorpi | O. Saramäki | K J Savinainen | M J Linja | O R Saramäki | T Visakorpi | M. Linja | K. Savinainen | T L Tammela
[1] N. Hay,et al. Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation. , 1994, Cancer research.
[2] S. Yeh,et al. Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[3] T. Visakorpi,et al. Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization. , 1994, Cytometry.
[4] C. Heid,et al. A novel method for real time quantitative RT-PCR. , 1996, Genome research.
[5] H. Klocker,et al. Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides , 2000, Cancer Gene Therapy.
[6] Thomas D. Schmittgen,et al. Real-Time Quantitative PCR , 2002 .
[7] J. Schleutker,et al. Androgen receptor gene mutations in hormone‐refractory prostate cancer , 1999, The Journal of pathology.
[8] Y. Kubota,et al. Fluorescence in situ hybridization evaluation of c‐myc and androgen receptor gene amplification and chromosomal anomalies in prostate cancer in Japanese patients , 2000, The Prostate.
[9] G. Wilding,et al. Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[10] S. Yeh,et al. From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[11] N. Rosen,et al. Synthesis and evaluation of geldanamycin-testosterone hybrids. , 2000, Bioorganic & medicinal chemistry letters.
[12] I. Bièche,et al. Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. , 1999, Cancer research.
[13] A. Friedl,et al. Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer. , 2000, Cancer research.
[14] G. Jenster,et al. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. , 1990, Biochemical and biophysical research communications.
[15] Jorma Isola,et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer , 1995, Nature Genetics.
[16] Schr,et al. Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. , 1994, The American journal of pathology.
[17] T. Tammela,et al. Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer. , 2000, The Journal of urology.
[18] J Isola,et al. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. , 1997, Cancer research.
[19] H. Klocker,et al. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor. , 1995, European urology.
[20] G. Prins,et al. Image analysis of androgen receptor immunostaining in prostate cancer accurately predicts response to hormonal therapy. , 1998, The Journal of urology.
[21] Donna M. Peehl,et al. Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor , 2000, Nature Medicine.
[22] L. Sobin,et al. Histological Typing of Prostate Tumours , 2002, World Health Organization.
[23] H. Klocker,et al. Distant metastases from prostatic carcinoma express androgen receptor protein. , 1995, Cancer research.
[24] J. Köllermann,et al. Undifferentiated carcinoma of the prostate with small cell features: immunohistochemical subtyping and reflections on histogenesis , 1999, Virchows Archiv.
[25] Noah Craft,et al. A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase , 1999, Nature Medicine.
[26] T. Visakorpi. New pieces to the prostate cancer puzzle , 1999, Nature Medicine.
[27] T. Tammela,et al. PSA Decline Is an Independent Prognostic Marker in Hormonally Treated Prostate Cancer , 1999, European Urology.
[28] P. Walsh,et al. Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy , 1991, Cancer.
[29] T C Gasser,et al. Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays. , 1999, Cancer research.
[30] J. Mulcahy,et al. Carcinoma of the prostate. , 1978, The Journal of the Kentucky Medical Association.
[31] U J Balis,et al. The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. , 1997, BioTechniques.
[32] D. Tindall,et al. Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP. , 1991, Cancer research.
[33] M. Schwab,et al. Oncogene amplification in tumor cells. , 1986, Advances in cancer research.
[34] G. Kristiansen,et al. Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue. , 2000, Urology.
[35] P. Humphrey,et al. Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening. , 1996, The Journal of urology.
[36] D. Horsfall,et al. Detection of discrete androgen receptor epitopes in prostate cancer by immunostaining: measurement by color video image analysis. , 1994, Cancer research.
[37] T. B. Morrison,et al. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. , 1998, BioTechniques.
[38] R L Vessella,et al. Characterization of a novel androgen-sensitive, prostate-specific antigen-producing prostatic carcinoma xenograft: LuCaP 23. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[39] T. Visakorpi,et al. Genetic basis and clonal evolution of human prostate cancer. , 1996, Advances in cancer research.
[40] E. Small,et al. Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist. , 1999, Cancer research.
[41] T. Libermann,et al. PDEF, a Novel Prostate Epithelium-specific Ets Transcription Factor, Interacts with the Androgen Receptor and Activates Prostate-specific Antigen Gene Expression* , 2000, The Journal of Biological Chemistry.
[42] G. Bubley,et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. , 1995, The New England journal of medicine.